Abhishek Agrawal

Bionest Partners, Inc. provides consulting services to the medical industry. The firm offers expertise in all aspects of the life sciences including medical devices, diagnostics, research and development, marketing, corporate development, and personal medicine strategy. The company was founded by Robert J. Easton in 2003 and is headquartered in New York, NY.

Gandiva, Inc. provides software solutions for business opportunities and challenges. Its product is Gandiva 4 end-to-end product support process that spans different business functions, systems and processes in an enterprise. The company was founded in 2000 by Ram Nidumolu and is located in Santa Clara, CA.

Zoic Capital LLC (Zoic Capital) is a venture capital firm founded in 2014 by Neal Mody and Eric Tan. The firm is headquartered in Seattle, Washington.

Gunas USA, Inc. is a fashion company that offers a collection of vegan leather bags, purses, shoes, and soap for men and women. Gunas USA is based in Long Island City, NY and was founded in 2009 by Sugandh G. Agrawal, who has been the CEO since then. The private company promotes sustainable and ethical fashion by using high-quality craftsmanship and handcrafting all their products using vegan leather. The company supports animal, human, and environmental welfare and have partnered with various animal welfare groups and sanctuaries.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.